Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 36

Sort by

Sort Order Select

Journal Articles

Aurora Kinase a Inhibition for Gvhd and Relapse Prevention after Allogeneic HCT: Phase I Trial in Combination with Ptcy/Sirolimus

Shernan G. Holtan, Kelly Walton, Najla H El Jurdi, Joseph E. Maakaron, Mark Juckett, Veronika Bachanova, Thomas Myers, Linda J. Paradiso, Todd DeFor, Qing Cao, Brian Betts

Blood (2023) 142 (Supplement 1): 4925.

https://doi.org/10.1182/blood-2023-181292

Published: 2023

Journal Articles

Post-Transplant Cyclophosphamide Eliminates Disparity in GvHD-Free, Relapse-Free Survival and Overall Survival between 8/8 Matched and 7/8 Mismatched Unrelated Donor Hematopoietic Cell Transplantation in Adults with Hematologic Malignancies

Jeffery J. Auletta, Monzr M. Al Malki, Todd DeFor, Brian C. Shaffer, Mahasweta Gooptu, Javier Bolanos-Meade, Ramzi Abboud, Adrienne D. Briggs, Farhad Khimani, Dipenkumar Modi, Richard Newcomb, Elizabeth J. Shpall, Caitrin Bupp, Stephen R. Spellman, Heather E. Stefanski, Antonio M. Jimenez Jimenez, Steven M. Devine

Blood (2023) 142 (Supplement 1): 780.

https://doi.org/10.1182/blood-2023-172722

Published: 2023

Journal Articles

Outcomes of transplantation using various hematopoietic cell sources in children with Hurler syndrome after myeloablative conditioning

Blood (2013) 121 (19): 3981–3987.

https://doi.org/10.1182/blood-2012-09-455238

Published: 2013

Journal Articles

Infusion of ex vivo expanded T regulatory cells in adults transplanted with umbilical cord blood: safety profile and detection kinetics

Claudio G. Brunstein, Jeffrey S. Miller, Qing Cao, David H. McKenna, Keli L. Hippen, Julie Curtsinger, Todd DeFor, Bruce L. Levine, Carl H. June, Pablo Rubinstein, Philip B. McGlave, Bruce R. Blazar, John E. Wagner

Blood (2011) 117 (3): 1061–1070.

https://doi.org/10.1182/blood-2010-07-293795

Published: 2011

Includes: Supplemental data

Journal Articles

Reduced Intensity Versus Myeloablative Conditioning in Adults with Acute Myeloid Leukemia Transplanted with Umbilical Cord Blood

Betul Oran, MD, MS, John E. Wagner, MD, Todd Defor, Daniel J. Weisdorf, MD, Claudio Brunstein, MD

Blood (2010) 116 (21): 3531.

https://doi.org/10.1182/blood.V116.21.3531.3531

Published: 2010

Journal Articles

Outcomes Following Allogeneic Hematopoietic Stem Cell Transplantation for Childhood Cerebral Variant Adrenoleukodystrophy: A Modern, Single-Institution Experience

Weston P Miller, IV, MD, Steven Rothman, MD, David Nascene, MD, Teresa Kivisto, RN, Todd Defor, Troy Lund, MD, PhD, Jakub Tolar, MD, PhD, Paul Orchard, MD

Blood (2010) 116 (21): 3543.

https://doi.org/10.1182/blood.V116.21.3543.3543

Published: 2010

Journal Articles

Impact of Graft Source on Immune Recovery: Comparions Between Unrelated Umbilical Cord Blood (UCB), HLA Matched Sibling (Sib) Donor and Autologous (Auto) Hematopoietic Stem Cells.

Sarah Cooley, MD, John E. Wagner, MD, Claudio Brunstein, MD, Mie Hagiwara, Giordi Orreggio, Julie Curtsinger, PhD, Todd Defor, Xianghua Luo, Bruce R. Blazar, MD, Phillip McGlave, MD, Jeffrey S. Miller, MD, Michael R Verneris, MD

Blood (2010) 116 (21): 3731.

https://doi.org/10.1182/blood.V116.21.3731.3731

Published: 2010

Journal Articles

Kinetics of Chimerism and Unit Predominance After Double Umbilical Cord Blood Transplantation

Pablo A. Ramirez, MD, John E. Wagner, MD, Todd Defor, MS, Bruce R. Blazar, MD, Michael Verneris, MD, Jeffrey S. Miller, MD, Daniel J. Weisdorf, MD, Phillip McGlave, MD, Claudio Brunstein, MD

Blood (2010) 116 (21): 225.

https://doi.org/10.1182/blood.V116.21.225.225

Published: 2010

Journal Articles

Relapse risk after umbilical cord blood transplantation: enhanced graft-versus-leukemia effect in recipients of 2 units

Michael R. Verneris, Claudio G. Brunstein, Juliet Barker, Margaret L. MacMillan, Todd DeFor, David H. McKenna, Michael J. Burke, Bruce R. Blazar, Jeffrey S. Miller, Philip B. McGlave, Daniel J. Weisdorf, John E. Wagner

Blood (2009) 114 (19): 4293–4299.

https://doi.org/10.1182/blood-2009-05-220525

Published: 2009

Journal Articles

Negative effect of KIR alloreactivity in recipients of umbilical cord blood transplant depends on transplantation conditioning intensity

Claudio G. Brunstein, John E. Wagner, Daniel J. Weisdorf, Sarah Cooley, Harriet Noreen, Juliet N. Barker, Todd DeFor, Michael R. Verneris, Bruce R. Blazar, Jeffrey S. Miller

Blood (2009) 113 (22): 5628–5634.

https://doi.org/10.1182/blood-2008-12-197467

Published: 2009

Includes: Supplemental data

Journal Articles

Prolonged survival in adults with acute lymphoblastic leukemia after reduced-intensity conditioning with cord blood or sibling donor transplantation

Veronika Bachanova, Michael R. Verneris, Todd DeFor, Claudio G. Brunstein, Daniel J. Weisdorf

Blood (2009) 113 (13): 2902–2905.

https://doi.org/10.1182/blood-2008-10-184093

Published: 2009

Journal Articles

Favorable Leukemia-Free Survival (LFS) for Adults and Children Undergoing Myeloablative Umbilical Cord Blood (UCB) Transplantation with Cyclophosphamide (CY), Fludarabine (FLU) and Total Body Irradiation (TBI): A Single Center Analysis of 194 Patients.

Claudio Brunstein, MD, PhD, Daniel Weisdorf, Todd DeFor, Jeffrey S. Miller, MD, Philip B. McGlave, Bruce R. Blazar, MD, John E. Wagner, MD

Blood (2008) 112 (11): 1957.

https://doi.org/10.1182/blood.V112.11.1957.1957

Published: 2008

Journal Articles

Negative Effect of KIR Alloreactivity in Recipients of Umbilical Cord Blood Transplantation Depends on Transplantation Conditioning Intensity

Claudio Brunstein, MD, PhD, John E. Wagner, MD, Daniel Weisdorf, MD, Sarah Cooley, MD, Harriet Noreen, Juliet Barker, MBBS, Todd DeFor, Michael Verneris, MD, Philip B. McGlave, Bruce R. Blazar, MD, Jeffrey S. Miller, MD

Blood (2008) 112 (11): 152.

https://doi.org/10.1182/blood.V112.11.152.152

Published: 2008

Journal Articles

Comparison of Two Mycophenolate Mofetil Dosing Regimens Following Hematopoietic Cell Transplantation (HCT).

Pamala A. Jacobson, PharmD, Sheiren Farag El-Massah, John Rogosheske, PharmD, Amber Kerr, RN, Janel Boyle-Long, PharmD, Todd DeFor, MS, Cathryn Jennisen, PharmD, Claudio Brunstein, MD, John E. Wagner, MD, Marcie Tomblyn, MD, Daniel Weisdorf, MD

Blood (2008) 112 (11): 1116.

https://doi.org/10.1182/blood.V112.11.1116.1116

Published: 2008

Journal Articles

Alternate Donor HCT for Fanconi Anemia (FA): Results of a Total Body Irradiation (TBI) Dose De-Escalation Study

Margaret L. MacMillan, MD, Bruce R. Blazar, MD, Todd DeFor, MS, Linan Ma, MSPH, Jakub Tolar, MD, Heather Zierhut, MS, John E. Wagner, MD

Blood (2008) 112 (11): 2998.

https://doi.org/10.1182/blood.V112.11.2998.2998

Published: 2008

Journal Articles

Incidence and Outcomes of Immune Thrombocytopenia (ITP) Following Hematopoietic Stem Cell Transplantation (HCT).

Milena Elimelakh, MD, Ted Eastlund, MD, Mark Reding, MD, Todd DeFor, MD, Linda Burns, MD

Blood (2007) 110 (11): 1316.

https://doi.org/10.1182/blood.V110.11.1316.1316

Published: 2007

Journal Articles

Higher Mycophenolate Dose Requirements in Children Undergoing Hematopoietic Cell Transplant (HCT).

Pamala A. Jacobson, PharmD, Jiayin Huang, MS, Nancy Rydholm, PharmD, MyHang Tran, PharmD, Todd DeFor, MS, Jakub Tolar, MD, PhD, Paul J. Orchard, MD

Blood (2007) 110 (11): 3011.

https://doi.org/10.1182/blood.V110.11.3011.3011

Published: 2007

Journal Articles

Lymphodepletion followed by donor lymphocyte infusion (DLI) causes significantly more acute graft-versus-host disease than DLI alone

Jeffrey S. Miller, Daniel J. Weisdorf, Linda J. Burns, Arne Slungaard, John E. Wagner, Michael R. Verneris, Sarah Cooley, Rosanna Wangen, Susan K. Fautsch, Roby Nicklow, Todd DeFor, Bruce R. Blazar

Blood (2007) 110 (7): 2761–2763.

https://doi.org/10.1182/blood-2007-05-090340

Published: 2007

Journal Articles

Double Umbilical Cord Blood Transplant Patients Have a Higher Risk of HHV-6 Infection.

Sharon F. Chen, MD, Todd DeFor, MS, Avis J. Thomas, MS, K. Scott Baker, MD, MS

Blood (2006) 108 (11): 5305.

https://doi.org/10.1182/blood.V108.11.5305.5305

Published: 2006

Journal Articles

Promising Progression Free and Overall Survival Using a Novel (CY/FLU/TBI) Reduced-Intensity Conditioning (RIC) Regimen for Allogeneic Sibling Stem Cell Transplantation (SCT).

Marcie Tomblyn, MD, MS, Jeffrey S. Miller, MD, Linda J. Burns, MD, Bruce R. Blazar, MD, PhD, Mukta Arora, MD, MS, Xianghua Luo, PhD, Todd Defor, MS, Claudio Brunstein, MD, PhD, Kathryn Dusenbery, MD, Margaret L. MacMillan, MD, Michael Verneris, MD, PhD, John Wagner, MD, Daniel J. Weisdorf, MD

Blood (2006) 108 (11): 2999.

https://doi.org/10.1182/blood.V108.11.2999.2999

Published: 2006

NARROW

Aurora Kinase a Inhibition for Gvhd and Relapse Prevention after Allogeneic HCT: Phase I Trial in Combination with Ptcy/Sirolimus

Post-Transplant Cyclophosphamide Eliminates Disparity in GvHD-Free, Relapse-Free Survival and Overall Survival between 8/8 Matched and 7/8 Mismatched Unrelated Donor Hematopoietic Cell Transplantation in Adults with Hematologic Malignancies

Outcomes of transplantation using various hematopoietic cell sources in children with Hurler syndrome after myeloablative conditioning

Infusion of ex vivo expanded T regulatory cells in adults transplanted with umbilical cord blood: safety profile and detection kinetics

Reduced Intensity Versus Myeloablative Conditioning in Adults with Acute Myeloid Leukemia Transplanted with Umbilical Cord Blood

Outcomes Following Allogeneic Hematopoietic Stem Cell Transplantation for Childhood Cerebral Variant Adrenoleukodystrophy: A Modern, Single-Institution Experience

Impact of Graft Source on Immune Recovery: Comparions Between Unrelated Umbilical Cord Blood (UCB), HLA Matched Sibling (Sib) Donor and Autologous (Auto) Hematopoietic Stem Cells.

Kinetics of Chimerism and Unit Predominance After Double Umbilical Cord Blood Transplantation

Relapse risk after umbilical cord blood transplantation: enhanced graft-versus-leukemia effect in recipients of 2 units

Negative effect of KIR alloreactivity in recipients of umbilical cord blood transplant depends on transplantation conditioning intensity

Prolonged survival in adults with acute lymphoblastic leukemia after reduced-intensity conditioning with cord blood or sibling donor transplantation

Favorable Leukemia-Free Survival (LFS) for Adults and Children Undergoing Myeloablative Umbilical Cord Blood (UCB) Transplantation with Cyclophosphamide (CY), Fludarabine (FLU) and Total Body Irradiation (TBI): A Single Center Analysis of 194 Patients.

Negative Effect of KIR Alloreactivity in Recipients of Umbilical Cord Blood Transplantation Depends on Transplantation Conditioning Intensity

Comparison of Two Mycophenolate Mofetil Dosing Regimens Following Hematopoietic Cell Transplantation (HCT).

Alternate Donor HCT for Fanconi Anemia (FA): Results of a Total Body Irradiation (TBI) Dose De-Escalation Study

Incidence and Outcomes of Immune Thrombocytopenia (ITP) Following Hematopoietic Stem Cell Transplantation (HCT).

Higher Mycophenolate Dose Requirements in Children Undergoing Hematopoietic Cell Transplant (HCT).

Lymphodepletion followed by donor lymphocyte infusion (DLI) causes significantly more acute graft-versus-host disease than DLI alone

Double Umbilical Cord Blood Transplant Patients Have a Higher Risk of HHV-6 Infection.

Promising Progression Free and Overall Survival Using a Novel (CY/FLU/TBI) Reduced-Intensity Conditioning (RIC) Regimen for Allogeneic Sibling Stem Cell Transplantation (SCT).

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only